(Reuters) – The U.S. Food and Drug Administration will conduct an expedited review of an experimental Alzheimer’s drug from Biogen Inc and Japan’s [...]
This website uses cookies to improve your user experience and to provide you with advertisements that are relevant to your interests. By continuing to browse the site you are agreeing to our use of cookies.Ok